ArticleCancer gene therapy2007

Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy.

H Kasuya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.